This by-invitation-only event will bring together a select group of life sciences executives to discuss best practices and strategies for U.S. companies looking to successfully expand into the European market. Among our esteemed guest speakers, we are delighted to include executives from Blueprint Medicines, who have successfully established operations across Europe and brought forward a rare disease medicine through the complex European market access and pricing environment. Besides the access & pricing challenges, we will also touch on some HR topics like timelines of hiring, and competitiveness of the market for top talents. Our speakers will share their valuable experiences and insights, while also engaging in an open debate about the opportunities available for U.S. biotech companies aiming to establish a presence in Europe.
Speaker
Georg Pirmin Meyer, SVP Head of International, Blueprint Medicines | 
Ulf Staginnus, VP International Market Acces & Pricing, Blueprint Medicines | |
Oliver Schiltz, Managing Director, Korn Ferry Switzerland | 
Thomas Fuchs, Deputy Head Economic Promotion, Canton of Zug | |
Moderation by 
Lukas Sieber, Executive Director North America, Greater Zurich Area Ltd. |
Want to write your own success story?
Discover all events where you can meet our expansion experts or partners
Meet with an expansion expert
Our services are free of charge and include:
- Introduction to key contacts in industry, academia, and government
- Advice on regulatory framework, taxes, labor, market, and setting up a company
- Custom-made fact-finding visits, including office and co-working space